Want to join the conversation?
For 3Q16, $SPLS expects sales to decrease vs. 3Q15. The company expects diluted non-GAAP EPS of $0.32-0.35 in 3Q16. The earnings guidance excludes potential charges related to strategic plans, including restructuring and related initiatives as well as the ongoing exploration of strategic alternatives for the company's European operations.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?